Skip to content
DeepHealth Brain

Population Health

DeepHealth Brain

Assess and monitor neurodegenerative changes with quantitative and reference data

DeepHealth Brain

DeepHealth Brain is an AI-powered clinical imaging solution for brain atrophy quantification and white matter hyperintensities (WMH) detection. It supports the assessment and monitoring of neurodegenerative changes with quantitative and reference data. FDA-cleared and CE-marked, DeepHealth Brain seamlessly integrates into existing workflows, with results, reports, and segmentations exported directly to PACS. It offers flexible deployment options, including on-site or cloud-based installation.

Book a demo

Brain atrophy analysis

WMH analysis

Comprehensive reports

Automated segmentation

“Using DeepHealth Brain enables us to provide our clinicians with valuable objective information derived from our MRI scans. Comparing the patient's results to a non-biased reference population makes it easier for clinicians to give patients insights into their atrophy development.”

Mario Muto

Director Diagnostic and Interventional Neuroradiology unit at Cardarelli Hospital, Naples

“During our MDT meetings, we always pull up the report from DeepHealth Brain and use it as extra information to come to a joint decision on the best diagnosis and clinical management of the patient.“

Meike Vernooij

Professor of Population Imaging at Erasmus MC, Rotterdam

Learn more

DeepHealth Introduces New AI-Powered Radiology Informatics and Population Screening Solutions at #ECR2025
press release

DeepHealth Introduces New AI-Powered Radiology Informatics and Population Screening Solutions at #ECR2025

Vienna, Austria, 26 February 2025 – DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), will introduce next-generation AI-powered radiology informatics and population screening solutions at the European Congress of Radiology (ECR) 2025 in Vienna. With the aim of empowering breakthroughs in care enabled by imaging, DeepHealth’s suite of solutions addresses critical clinical and operational challenges experienced by healthcare providers around the world.

Read more
Siemens Healthineers and RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™
press release

Siemens Healthineers and RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Collaborate Around Elevating Ultrasound Workflows with AI-Powered SmartTechnology™

December 1, 2024 – Siemens Healthineers and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today announced a strategic collaboration aimed at transforming ultrasound operations through the implementation of SmartTechnology™ by embedding AI-powered health informatics within workflows and imaging hardware.

Read more
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer
press release

RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer

Los Angeles, CA and Nashua, NH – April 15, 2025, RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, and iCAD, Inc. (NASDAQ: ICAD) (“iCAD”), a global leader in providing clinically proven AI-powered breast health solutions, announced today that they have entered into a definitive merger agreement under which RadNet will acquire iCAD in an all stock transaction.

Read more
Disclaimers: DeepHealth Brain is manufactured as Quantib ND by Quantib BV for DeepHealth Inc. Not all products and functionalities are commercially available in all countries. For clearance and commercial availability in your geography of functionalities listed and compatibility with other systems, please contact us.